StratDeck

Two stocks in Healthcare

Bristol-Myers Squibb vs Medtronic: profit, growth, debt and price compared

Bristol-Myers Squibb and Medtronic are each stronger on 3 of 7 figures: Bristol-Myers Squibb on profit margin, price for its expected profit and dividend; Medtronic on sales growth, debt and price trend.

Figures as of 18 November 2026SEC EDGARYahoo Finance
Explore Bristol-Myers Squibb's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Bristol-Myers Squibb and Medtronic side by side
Bristol-Myers SquibbBMYMedtronicMDT
Net marginStronger: 18.5%13.9%
Revenue growth, past year+6.93%Stronger: +13.73%
Debt to equity191.5%Stronger: 55.4%
Forward P/EStronger: 8.9×15.7×
Dividend yieldStronger: 4.23%2.83%
AnalystsBuy · 24Buy · 26
From its 200-day average+1.2%Stronger: +12.5%

Share price over the past year

  • Bristol-Myers Squibb+26.6%
  • Medtronic−0.1%

18 Nov 202518 Nov 2026

Bristol-Myers Squibb or Medtronic: which is stronger?

  • BMY

    Which is more profitable?

    Bristol-Myers Squibb keeps more of each sale as profit: 18.5% against 13.9%.

  • MDT

    Which is growing its sales faster?

    Medtronic is growing its sales faster: +13.73% over the past year, against +6.93%.

  • MDT

    Which has borrowed less?

    Medtronic has borrowed less: its debt is 55.4% of what its shareholders own, against 191.5% for Bristol-Myers Squibb.

  • BMY

    Which costs less for the profit it is expected to make?

    Bristol-Myers Squibb costs less for the profit it is expected to make: 8.9× its forward earnings, against 15.7×.

  • BMY

    Which pays more in dividends?

    Bristol-Myers Squibb pays more back in dividends for what a share costs: 4.23% a year, against 2.83%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • MDT

    Which is in the stronger price trend?

    Medtronic's price is in the stronger trend: 12.5% above its 200-day average, against 1.2% above.

What each company does

BMYBristol-Myers Squibb

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

Reports results on 4 February 2027

MDTMedtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally.

Reports results on 24 November 2026

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every US healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.